October Funded Grants

Funded Awards


PI Agency Title
Sesh Cole CHOP CHOP / PEDSnet Data Coordinating Center 2
Megan Cooper SLCH Foundation Modell Foundation- Family Assistance Award
Patricia Dickson NIH/SBIR/STTR/Tega Therapeutics Intracerebroventricular Alpha-N-Acetylglucosaminidase Delivery to the Brain
Patricia Dickson Genzyme The Role of Angiotensin II-Mediated Inflammation in MPS I Vascular Disease: A study of pathophysiologic mechanism and evaluation of angiotensin receptor blockade therapy
Misty Good SLCH Foundation Modulation of the Intestinal Immune Response in Hirschsprung’s Associated Enterocolitis
Monica Hulbert Illinois Department of Public Health Sickle Cell Follow Up 2020
David Hunstad SLCH Foundation Catlin Funding – ID Fellow Continuing Education Support
Mark Manary DDRF Lactose for the malnourished gut
Brigida Rusconi Washington University Digesitive Diseases Research Core Center The Role of Sphingolipid Signaling in Early Life Mucosal Immune Establishment
Gregory Storch NIH/University of Alabama, Birmingham DMID 19-0005: A Prospective Study of Acute Flaccid Myelitis (AFM) to Define Natural History, Risk Factors, and Pathogenetic Mechanisms
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …